A5V4d
A5V4d
A5V4d
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ibuprofen compared with paracetamol and ibuprofen combined<br />
ibuprofen compared with paracetamol and ibuprofen alternating<br />
Antipyretic interventions<br />
paracetamol and ibuprofen combined compared with paracetamol and ibuprofen<br />
alternating.<br />
Description of included studies<br />
Twenty-five studies were included in this review (Gupta et al., 2007; Walson et al., 1989; Kauffman et<br />
al., 1992; Wilson et al., 1991; Brewer et al., 1968; Autret et al., 1997; Nadal et al., 2002; Sarrell et al.,<br />
2006; Wong et al., 2001; Erlewyn-Lajeunesse et al., 2006; Sidler et al., 1990; Ulukol et al., 1999;<br />
Autret et al., 1994; McIntyre et al., 1996; Vauzelle-Kervrodan et al., 1997; Van Esch et al., 1995;<br />
Autret-Leca et al., 2007; Southey et al., 2009; Beasley et al., 2008; Pierce et al., 2010;Hay et al.,<br />
2009; Pashapour et al., 2009; Kramer et al., 2008; Paul et al., 2010; Nabulsi et al., 2006). No studies<br />
were identified comparing alternating or combining antipyretics with placebo.<br />
All the identified studies were RCTs, meta-analyses of RCTs or large case series. Studies were<br />
mainly undertaken in Europe and North America. Study dates ranged from the 1980s to 2010.<br />
Assessment of effectiveness was hampered by the heterogeneity of study protocols, with different<br />
entry criteria, outcomes, measurement times and dosages of drugs being used. As a result of this<br />
heterogeneity, a meta-analysis was not undertaken.<br />
A number of calculations have been used in this review. For a relative risk, an effect size of 0.25 with<br />
the 95% confidence interval (CI) not crossing 1 (no effect) was considered a large effect. For<br />
standardised mean differences, an effect size of 0.1 was considered small, 0.3 medium and 0.5 large.<br />
Evidence profile<br />
Evidence was found for 8 of the 10 comparisons and results of these studies are summarised in the<br />
following GRADE tables (for full evidence profiles see Appendix I):<br />
Table 9.2 − paracetamol compared with placebo<br />
Table 9.3 − ibuprofen compared with placebo<br />
Table 9.4 − paracetamol compared with ibuprofen<br />
Table 9.5 −paracetamol compared with paracetamol and ibuprofen combined<br />
Table 9.6 − paracetamol compared with paracetamol and ibuprofen alternating<br />
Table 9.7 − ibuprofen compared with paracetamol and ibuprofen combined<br />
Table 9.8 − ibuprofen vparacetamol and ibuprofen alternating<br />
Table 9.9 − paracetamol and ibuprofen combined compared with paracetamol and<br />
ibuprofen alternating.<br />
199<br />
2013 Update